Skip to main content

Advertisement

Log in

Postoperative application of amphotericin B nasal spray in chronic rhinosinusitis with nasal polyposis, with a review of the antifungal therapy

  • Rhinology
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Chronic rhinosinusitis (CRS) affects 1–4% of the adult population. The etiology of this multifactorial, chronic disease, which leads to a significant impairment of the quality of life, often accompanied by nasal polyposis, is not fully understood. In the past decade, it was presumed that the disease, which causes characteristic eosinophilic infiltration of the nasal mucosa, is triggered by an enhanced (but not classical allergic IgE-type) immune response against fungal organisms in the nasal mucus. If this supposition is correct, then it appears obvious that the administration of amphotericin B nasal spray in adequate concentration following endoscopic polypectomy should be advantageous for these patients, and might even reduce the number of recurrent cases. To check on this assumption, we conducted a prospective randomized placebo-controlled trial involving 33 patients, 30 of whom remained in the study throughout. Patients with nasal polyposis were operated on with an endoscopic technique between 1 November 2005 and 1 October 2006; group A (14 randomly selected patients) were treated with a nasal spray containing 5 mg/ml amphotericin B, while the placebo group B (16 randomly selected patients) received a nasal spray lacking amphotericin B. We evaluated our results with the aid of a modified Lund–Mackay CT score, the SNAQ-11 test (which assesses changes in the symptoms), a quality of life test and endoscopy. The SPSS 14.0 for Windows program was utilized to process the data of examinations performed preoperatively and 1 year postoperatively. The CT scores of the group A patients 1 year after the operation exhibited wide scattering, without signs of recovery. The CT scores of the group B patients indicated a slight improvement, though this did not prove significant relative to group A. Both the SNAQ-11 test and the quality of life test revealed a significant improvement in each group, but the degrees of change in these tests did not differ significantly between the two groups of patients. The endoscopic findings indicated a slight improvement to the advantage of the amphotericin B-treated group 12 months after the operation. These results lead to the conclusion that the administration of amphotericin B nasal spray to patients operated on for nasal polyposis does not give rise to a significant alteration in either CT score, clinical symptoms, or quality of life. The more favorable clinical aspects observed in the amphotericin B-treated group during the endoscopic follow-up did not correspond to an improvement in the symptoms. In connection with the conclusions drawn from this study, the authors discuss the controversial data available on the fungal etiology of CRS. They critically analyze the contradictory observations and conclusions of seven recent clinical studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Lanza DC, Kennedy DW (1997) Adult rhinosinusitis defined. Otolaryngol Head Neck Surg 117:S1–S7. doi:10.1016/S0194-5998(97)70001-9

    Article  PubMed  CAS  Google Scholar 

  2. Hedman J, Kaprio J, Poussa T, Nieminen MM (1999) Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. Int J Epidemiol 28:717–722. doi:10.1093/ije/28.4.717

    Article  PubMed  CAS  Google Scholar 

  3. Fokkens W, Lund V, Mullol J et al (2007) European position paper (EPP) on rhinosinusitis and nasal polyps 2007. Rhinol Suppl 20:1–136

    PubMed  Google Scholar 

  4. Bent JP, Kuhn FA (1994) Diagnosis of allergic fungal rhinosinusitis. Otolaryngol Head Neck Surg 111:580–588. doi:10.1016/S0194-5998(94)70525-9

    Article  PubMed  Google Scholar 

  5. Hirschberg A, Jókúti A, Darvas Z, Almay K, Répássy G, Falus A (2003) The pathogenesis of nasal polyposis by immunoglobulin E and interleukin-5 is completed by transforming growth factor-beta 1. Laryngoscope 113:120–124. doi:10.1097/00005537-200301000-00022

    Article  PubMed  CAS  Google Scholar 

  6. Sanclement JA, Webster P, Thomas J, Ramadan HH (2005) Bacterial biofilms in surgical specimens of patients with chronic rhinosinusitis. Laryngoscope 115:578–582

    PubMed  Google Scholar 

  7. Douglas R, Bruhn M, Tan LW, Ooi E, Psaltis A, Wormald PJ (2007) Response of peripheral blood lymphocytes to fungal extracts and staphylococcal superantigen B in chronic rhinosinusitis. Laryngoscope 117:411–414. doi:10.1097/MLG.0b013e31802c0707

    Article  PubMed  Google Scholar 

  8. Braun H, Buzina W, Freudenschuss K, Beham A, Stammberger H (2003) “Eosinophilic fungal rhinosinusitis”: a common disorder in Europe? Laryngoscope 113:264–269. doi:10.1097/00005537-200302000-00013

    Article  PubMed  Google Scholar 

  9. Katzenstein A, Sale G, Greenberger P (1982) Pathologic findings in allergic aspergillus sinusitis. J Allergy Clin Immunol 72:89–93. doi:10.1016/0091-6749(83)90057-X

    Article  Google Scholar 

  10. DeShazo RD, Swain RE (1995) Diagnostic criteria for allergic fungal sinusitis. J Allergy Clin Immunol 96:24–35. doi:10.1016/S0091-6749(95)70029-3

    Article  PubMed  CAS  Google Scholar 

  11. Ponikau JU, Sherris DA, Kita H, Kern EB (2002) Intranasal antifungal treatment in 51 patients with chronic rhinosinusitis. Allergy Clin Immun 110:862–866. doi:10.1067/mai.2002.130051

    Article  CAS  Google Scholar 

  12. Ponikau JU, Sherris DA, Kephart EB, Humburger HA, Frigas E, Gaffey TA et al (1999) The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc 28:1145–1152

    Google Scholar 

  13. Ponikau JU, Sherris JA, Weaver A, Kita H (2005) Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomised, placebo-controlled, double-blind pilot trial. J Allergy Clin Immunol 115:125–131. doi:10.1016/j.jaci.2004.09.037

    Article  PubMed  CAS  Google Scholar 

  14. Pant H, Kette FE, Smiths WB, Macardle PJ, Wormald PJ (2006) Eosinophil mucus chronic rhinosinusitis: clinical subgroups or a homogenous pathogenetic entity? Laryngoscope 116:1241–1247. doi:10.1097/01.mlg.0000224547.14519.ad

    Article  PubMed  Google Scholar 

  15. Erbek SS, Serefhanoglu K, Erbek S, Demirbilek M, Can F, Tarhan E et al (2008) Clinical subgroups and antifungal susceptibilities in fungal-culture positive patients with chronic rhinosinusitis. Eur Arch Otorhinolaryngol 265(7):775–780

    Article  PubMed  Google Scholar 

  16. Corradini C, Del Ninno M, Buonomo A, Nucera E, Paludetti G, Alonzi C et al (2006) (Amphotericin B and lysine acetylsalicylate in the combined treatment of nasal polyposis associated with mycotic infection. J Investig Allergol Clin Immunol 16:188–193

    PubMed  CAS  Google Scholar 

  17. Ebbens FA, Scadding GK, Badia L, Hellings PW, Jorissen M, Mullol J, Cardesin A, Bachert C, van Zele TP, Dijkgrawf MG, Lund V, Fokkens WJ (2006) Amphotericin B nasal lavages: not a solution for patient with chronic rhinosinusitis. J Allergy Clin Immunol 118:1149–1156. doi:10.1016/j.jaci.2006.07.058

    Article  PubMed  CAS  Google Scholar 

  18. Helbling A, Baumann A, Hänni C, Caversaccio M (2006) Amphotericin B nasal spray has no effect on nasal polyps. J Laryngol Otol 120:1023–1025. doi:10.1017/S0022215106002167

    Article  PubMed  CAS  Google Scholar 

  19. Ricchetti A, Landis BN, Maffioli A, Giger R, Zeng C, Lacroix JS (2002) Effect of anti-fungal nasal lavage with amphotericin B on nasal polyposis. J Laryngol Otol 116:261–263

    Article  PubMed  Google Scholar 

  20. Weschta M, Rimek D, Formanek M, Polzehl D, Podbielski A, Reichelmann H (2004) Topical antifungal treatment of chronic rhinosinusitis with nasal polyps: a randomized, double-blind clinical trial. J Allergy Clin Immunol 113:1122–1128. doi:10.1016/j.jaci.2004.03.038

    Article  PubMed  CAS  Google Scholar 

  21. Juniper EF, Thompson AK, Ferrie PJ, Roberts JN (2000) Development and validation of the mini Rhinoconjunctivitis Quality of Life Questionnaire. Clin Exp Allergy 30:132–140. doi:10.1046/j.1365-2222.2000.00668.x

    Article  PubMed  CAS  Google Scholar 

  22. Lund VJ, Mackay IS (1993) Staging in rhinosinusitis. Rhinology 31:183–184

    PubMed  CAS  Google Scholar 

  23. Fahmy FF, McCombe A, Mckiernan DC (2002) Sino-nasal outcome questionnaire, a patient focussed, rhinosinusitis specific outcome measure. Rhinology 40:195–197

    PubMed  CAS  Google Scholar 

  24. Basu S, Georgalas C, Kumar BN, Desai S (2005) Correlation between symptoms and radiological findings in patients with chronic rhinosinusitis: an evaluation study using the Sinonasal Assessment Questionnaire and Lund–Mackay grading system. Eur Arch Otorhinolaryngol 262:751–754. doi:10.1007/s00405-004-0891-0

    Article  PubMed  CAS  Google Scholar 

  25. Malm L (1997) Assessment and staging of nasal polyposis. Acta Otolaryngol 117:465–467. doi:10.3109/00016489709113422

    Article  PubMed  CAS  Google Scholar 

  26. Shin S, Ponikau JU, Sherris DA, Congdon D, Frigas E, Homburger HA et al (2004) Chronic rhinosinusitis: an enhanced immune response to ubiquitous airborne fungi. J Allergy Clin Immunol 114:1369–1375. doi:10.1016/j.jaci.2004.08.012

    Article  PubMed  CAS  Google Scholar 

  27. Collins M, Nair S, Smiths W, Kette F, Gillis D, Wormald PJ (2004) Role of local immunoglobulin E production in the pathophysiology of non-invasive fungal sinusitis. Laryngoscope 114:1242–1246. doi:10.1097/00005537-200407000-00019

    Article  PubMed  CAS  Google Scholar 

  28. Gosepath J, Brieger J, Vlachtsis K, Mann WJ (2004) Fungal DNA is present in tissue specimens of patients with chronic rhinosinusitis. Am J Rhinol 18:9–13

    PubMed  Google Scholar 

  29. Seung-Heon S, Mi-Kiung Y (2004) Effect of topical amphotericin B on expression of cytokines in nasal polyps. Acta Otolaryngol 124:1174–1177. doi:10.1080/00016480410017404

    Article  CAS  Google Scholar 

  30. Weschta M, Rimek D, Formanek M, Podbielski A, Riechelmann H (2006) Effect of nasal antifungal therapy on nasal cell activation markers in chronic rhinosinusitis. Arch Otolaryngol Head Neck Surg 132:743–747. doi:10.1001/archotol.132.7.743

    Article  PubMed  Google Scholar 

  31. Heatley DG, McConnell KE, Kille TL, Leverson GE (2001) Nasal irrigation for the alleviation of sinonasal symptoms. Otolaryngol Head Neck Surg 125:44–48. doi:10.1067/mhn.2001.115909

    Article  PubMed  CAS  Google Scholar 

  32. Wormald PJ, Cain T, Oates L, Hawke L, Wong I (2004) A comparative study of three methods of nasal irrigation. Laryngoscope 114:2224–2227. doi:10.1097/01.mlg.0000149463.95950.c5

    Article  PubMed  Google Scholar 

  33. Tomooka LT, Murphy C, Davidson TM (2000) Clinical study and literature review of nasal irrigation. Laryngoscope 110:1189–1193. doi:10.1097/00005537-200007000-00023

    Article  PubMed  CAS  Google Scholar 

  34. Wildfeuer A, Seidl HP, Paule I, Haberreiter A (1997) In vitro evaluation of variconazole against clinical isolates of yeasts, moulds and dermatophytes in comparison with itraconazole, ketoconazole, amphotericin B and griseofulvin. Mycoses 41:309–319

    Article  Google Scholar 

  35. Fittler A, Mayer A, Kocsis B, Gerlinger I, Fónay F, Botz L (2007) Stability testing of amphotericin B nasal spray solutions with chemical and biological analysis. Acta Pharm Hung 77:159–164

    PubMed  Google Scholar 

  36. Bhattacharyya T, Piccirillo J, Wippold FJ (1997) Relationship between patient based descriptions of sinusitis and paranasal sinus computed tomographic findings. Arch Otolaryngol Head Neck Surg 123:1189–1192

    PubMed  CAS  Google Scholar 

  37. Kenny TJ, Duncavage J, Bracikowski J, Yildirim A, Murray JJ, Tanner SB (2001) Prospective analysis of sinus symptoms and correlation with paranasal computed tomography scan. Otolaryngol Head Neck Surg 125:40–43. doi:10.1067/mhn.2001.116779

    Article  PubMed  CAS  Google Scholar 

  38. Jornot L, Rochat T, Caruso A, Lacroix J (2005) Effects of amphotericin B on ion transport proteins in airway epithelial cells. J Cell Physiol 204:859–870. doi:10.1002/jcp.20347

    Article  PubMed  CAS  Google Scholar 

  39. Sokol-Anderson ML, Brajtburg J, Medoff G (1986) Amphotericin B-induced oxidative damage and killing of Candida albicans. J Infect Dis 154:76–83

    PubMed  CAS  Google Scholar 

  40. Kennedy DW, Kuhn FA, Hamilos DI (2005) Treatment of chronic rhinosinusitis with high-dose oral terbinafine: a double blind placebo-controlled study. Laryngoscope 115:1793–1799. doi:10.1097/01.mlg.0000175683.81260.26

    Article  PubMed  CAS  Google Scholar 

  41. Rains BM, Mineck CW (2003) Treatment of allergic fungal sinusitis with high-dose itraconazole. Am J Rhinol 17:1–8

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to I. Gerlinger.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gerlinger, I., Fittler, A., Fónai, F. et al. Postoperative application of amphotericin B nasal spray in chronic rhinosinusitis with nasal polyposis, with a review of the antifungal therapy. Eur Arch Otorhinolaryngol 266, 847–855 (2009). https://doi.org/10.1007/s00405-008-0836-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-008-0836-0

Keywords

Navigation